Your browser doesn't support javascript.
loading
The evaluation of 7 commercial real-time PCR kits for Zaire ebolavirus using virus-like particle-encapsulated EBOV RNA.
Wang, Guojing; Zhang, Rui; Han, Yanxi; Chang, Le; Zhang, Dong; Zhang, Lei; Yang, Xin; Liu, Chao; Ding, Jiansheng; Zhang, Kuo; Lin, Guigao; Jiehong, Xie; Li, Jinming.
Afiliação
  • Wang G; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China; Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Zhang R; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China.
  • Han Y; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China.
  • Chang L; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China; Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Zhang D; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China; Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Zhang L; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China; Fifth School of Clinical Medicine, Peking University, Beijing, People's Republic of China.
  • Yang X; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China; Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Liu C; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China; Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Ding J; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China; Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Zhang K; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China.
  • Lin G; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China.
  • Jiehong X; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China.
  • Li J; National Center for Clinical Laboratories, Beijing Hospital of National Health and Family Planning Commission, Beijing, People's Republic of China; Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China. Electronic address: jmli@nccl.o
Diagn Microbiol Infect Dis ; 83(4): 355-8, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26431829
Several Chinese commercial real-time PCR kits for Zaire ebolavirus have been developed after the Ebola outbreak and used by Chinese medical teams in West Africa. In order to know the essential performance indicators of these kits, analytical sensitivity and precision were evaluated with virus-like particle (VLP)-encapsulated EBOV RNA. The limit of detection (LOD) and the precision were completed with a series of VLPs. The maximum and minimum of LOD was acquired by ZJ BioTech and Daan gene, respectively. For precision, all of the detection results were <5% except the maximum 5.17%. Among them, Puruikang, Daan gene, Sansure, ZJ BioTech, and Huada demonstrated superior reproducibility. Overall, the requirements of LOD <1000 copies/mL and coefficient of variation <5% could be satisfied by all kits except Kehua. Meanwhile, it is feasible for VLPs as a substitute of positive samples in assay evaluation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Kit de Reagentes para Diagnóstico / RNA Viral / Doença pelo Vírus Ebola / Técnicas de Diagnóstico Molecular / Ebolavirus / Reação em Cadeia da Polimerase em Tempo Real Tipo de estudo: Diagnostic_studies / Evaluation_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Kit de Reagentes para Diagnóstico / RNA Viral / Doença pelo Vírus Ebola / Técnicas de Diagnóstico Molecular / Ebolavirus / Reação em Cadeia da Polimerase em Tempo Real Tipo de estudo: Diagnostic_studies / Evaluation_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article